Shenzhen Kangtai Biological Products Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 871.43 million compared to CNY 276.99 million a year ago. Revenue was CNY 871.43 million compared to CNY 276.99 million a year ago. Net income was CNY 273.59 million compared to CNY 25.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.2482 compared to CNY 0.0231 a year ago. Diluted earnings per share from continuing operations was CNY 0.2482 compared to CNY 0.0228 a year ago.